company background image
OMCL logo

Omnicell NasdaqGS:OMCL Stock Report

Last Price

US$29.24

Market Cap

US$1.3b

7D

4.7%

1Y

-47.3%

Updated

27 Mar, 2024

Data

Company Financials +

OMCL Stock Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.

OMCL fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Omnicell, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Omnicell
Historical stock prices
Current Share PriceUS$29.24
52 Week HighUS$77.14
52 Week LowUS$25.69
Beta0.74
1 Month Change4.69%
3 Month Change-24.76%
1 Year Change-47.33%
3 Year Change-77.49%
5 Year Change-63.64%
Change since IPO207.47%

Recent News & Updates

An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued

Mar 28
An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued

Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues

Feb 29
Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues

Recent updates

An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued

Mar 28
An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued

Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues

Feb 29
Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues

Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Feb 23
Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell Is Building A Strong Moat

Feb 22

Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?

Jan 15
Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Dec 25
Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?

Dec 06
Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?

Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%

Nov 10
Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?

Sep 06
Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?

Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?

Aug 08
Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?

Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching

Jul 02
Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching

A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)

Jun 08
A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)

Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital

Apr 29
Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital

Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?

Apr 11
Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?

At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?

Mar 23
At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?

Feb 28
Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?

Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)

Jan 15
Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)

We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt

Jan 01
We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?

Nov 17
Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?

Analysts Just Slashed Their Omnicell, Inc. (NASDAQ:OMCL) EPS Numbers

Nov 03
Analysts Just Slashed Their Omnicell, Inc. (NASDAQ:OMCL) EPS Numbers

Omnicell launches Specialty Pharmacy Services

Oct 11

Omnicell (NASDAQ:OMCL) Seems To Use Debt Quite Sensibly

Sep 30
Omnicell (NASDAQ:OMCL) Seems To Use Debt Quite Sensibly

Omnicell says advance services to drive profitable growth in long-run: Investor Day

Sep 20

Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Sep 15
Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell (NASDAQ:OMCL) Might Have The Makings Of A Multi-Bagger

Aug 31
Omnicell (NASDAQ:OMCL) Might Have The Makings Of A Multi-Bagger

Omnicell reports Q2 earnings miss; reaffirms FY22 guidance and issues Q3 outlook

Aug 04

Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 41%?

Aug 03
Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 41%?

Omnicell Fails To Justify Inclusion In Long-Only, Equity-Focused Portfolio

Jul 21

We Ran A Stock Scan For Earnings Growth And Omnicell (NASDAQ:OMCL) Passed With Ease

Jun 27
We Ran A Stock Scan For Earnings Growth And Omnicell (NASDAQ:OMCL) Passed With Ease

Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Jun 13
Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell's (NASDAQ:OMCL) Returns On Capital Are Heading Higher

May 30
Omnicell's (NASDAQ:OMCL) Returns On Capital Are Heading Higher

These 4 Measures Indicate That Omnicell (NASDAQ:OMCL) Is Using Debt Safely

May 05
These 4 Measures Indicate That Omnicell (NASDAQ:OMCL) Is Using Debt Safely

With EPS Growth And More, Omnicell (NASDAQ:OMCL) Is Interesting

Mar 16
With EPS Growth And More, Omnicell (NASDAQ:OMCL) Is Interesting

What Is Omnicell, Inc.'s (NASDAQ:OMCL) Share Price Doing?

Mar 04
What Is Omnicell, Inc.'s (NASDAQ:OMCL) Share Price Doing?

Omnicell (NASDAQ:OMCL) Is Looking To Continue Growing Its Returns On Capital

Feb 20
Omnicell (NASDAQ:OMCL) Is Looking To Continue Growing Its Returns On Capital

Shareholder Returns

OMCLUS Medical EquipmentUS Market
7D4.7%2.2%0.4%
1Y-47.3%13.3%28.8%

Return vs Industry: OMCL underperformed the US Medical Equipment industry which returned 12% over the past year.

Return vs Market: OMCL underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is OMCL's price volatile compared to industry and market?
OMCL volatility
OMCL Average Weekly Movement7.1%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: OMCL's share price has been volatile over the past 3 months.

Volatility Over Time: OMCL's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19923,650Randy Lippshttps://www.omnicell.com

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software.

Omnicell, Inc. Fundamentals Summary

How do Omnicell's earnings and revenue compare to its market cap?
OMCL fundamental statistics
Market capUS$1.34b
Earnings (TTM)-US$20.37m
Revenue (TTM)US$1.15b

1.2x

P/S Ratio

-65.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OMCL income statement (TTM)
RevenueUS$1.15b
Cost of RevenueUS$647.18m
Gross ProfitUS$499.93m
Other ExpensesUS$520.30m
Earnings-US$20.37m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.44
Gross Margin43.58%
Net Profit Margin-1.78%
Debt/Equity Ratio47.9%

How did OMCL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.